<div><p>Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and inhibitors, represents an important task for predicting drug-drug interactions. A quantitative assessment of the ligand binding affinity towards different CYPs can provide an estimate of inhibitory activity or an indication of isoforms prone to interact with the substrate of inhibitors. However, the accuracy of global quantitative models for CYP substrate binding or inhibition based on traditional molecular descriptors can be limited, because of the lack of information on the structure and flexibility of the catalytic site of CYPs. Here we describe the application of a method that combines protein-ligand docking, Molecular Dynamics (M...
Background: Early in-vitro consideration of metabolism and inhibition of cytochrome P450 has proven ...
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast...
One aspect of drug design involves filtering libraries of existing compounds in order to select thos...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and ...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and ...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., sub-strates and...
Predicting binding affinities for receptor-ligand complexes is still one of the challenging processe...
Predicting binding affinities for receptor-ligand complexes is still one of the challenging processe...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Accurate ligand-protein binding affinity prediction, for a set of similar binders, is a major challe...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Binding affinity prediction of potential drugs to target and off-target proteins is an essential ass...
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast...
Background: Early in-vitro consideration of metabolism and inhibition of cytochrome P450 has proven ...
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast...
One aspect of drug design involves filtering libraries of existing compounds in order to select thos...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and ...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and ...
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., sub-strates and...
Predicting binding affinities for receptor-ligand complexes is still one of the challenging processe...
Predicting binding affinities for receptor-ligand complexes is still one of the challenging processe...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Accurate ligand-protein binding affinity prediction, for a set of similar binders, is a major challe...
Because of the large flexibility and malleability of Cytochrome P450 enzymes (CYPs), in silico predi...
Binding affinity prediction of potential drugs to target and off-target proteins is an essential ass...
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast...
Background: Early in-vitro consideration of metabolism and inhibition of cytochrome P450 has proven ...
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast...
One aspect of drug design involves filtering libraries of existing compounds in order to select thos...